market

'Near Perfect' Indicator That Precedes Almost Every Stock Market …

‘Near Perfect’ Indicator That Precedes Almost Every Stock Market Correction Is Flashing A Warning Signal
By Michael Snyder, on December 4th, 2014Are we about to see U.S. stocks take a significant tumble?  If you are looking for a “canary in the coal mine” for the U.S. stock market, just look at high yield bonds.  In recent years, almost every single […]

What does a Dead Cat Bounce pattern tells traders about a stock?

A:A dead cat bounce is a technical trading pattern that signals to traders the continuation of a downtrend, that a stock’s price is likely to continue to decline. The chart pattern appears when only a small, short-lived recovery follows a significant, severe decline in a stock’s price. This trading pattern is considered a relatively definitive indicator of market weakness. It […]

Investors Are Getting Increasingly Panicked About A Potential Stock…

Yale via Schwab.comThe Crash Confidence Index has gone down steadily since the beginning of 2014.FA Insights is a daily newsletter from Business Insider that delivers the top news and commentary for financial advisors. Investors Are Getting Increasingly Worried About A Market Crash (Charles Schwab)Investment strategist Liz Ann Sonders considers several measures of individual and institutional investor sentiment in her latest market perspective […]

Stock Trading for Beginners: Where Do I Start?

So you’ve decided to become involved in the stock market but don’t really know where to start? Well first off, congratulations! The stock market is a great investment that can pay off huge when done right! Now remember, the first step is always the hardest in anything you do so we have put together a list of three fantastic ways […]

Exclusive: Citigroup To Shutter Lavaflow Stock Trading Venue …

REUTERS/Brendan McDermid12:37 PM 12/02/14By John McCrankNEW YORK (Reuters) – Citigroup Inc is shutting down its alternative stock trading venue LavaFlow, the bank said on Tuesday, at a time when regulatory scrutiny has increased around broker-run trading platforms, forcing banks to rethink the costs.Critics say the alternative stock trading venues add to the fragmentation of the market, increasing complexity and costs […]

Is Exelixis, Inc. Stock Doomed?

Biotech stocks are infamous for their volatile ways — shooting higher one minute, only to crater the next. After a biotech crashes, investors should always assess their options going forward. Sometimes a marked sell-off represents a compelling buying opportunity that can pay off handsomely over the long run. On the other hand, a mass shareholder exodus can trigger a series of events […]

Could This Biotech Stock Fall Even Further?

View gallery.Sometimes the stock market gets on a run and traders enjoy the ride.The same can apply with individual stocks. Once the wind is at their backs, traders can take off and run to previously unforeseen heights.However, all runs must come to an end eventually. The million-dollar question is, when?This is where technical analysis can sometimes help.Commonly, stocks getting ready […]

BTIG's 2015 S&P 500 Forecast: 2,200 – Business Insider

BritneySpearsVEVO”I’m not a girl. Not yet a woman.” -Britney SpearsSee AlsoGOLDMAN: The Stock Market In 2015 Will Be … MehUBS On Stocks: ‘Roll Tide, Roll…’BAML: US Stocks Will Squeak Out A Tiny Gain In 2015BTIG’s Dan Greenhaus borrows from Britney Spears’ 2001 song “I’m Not a Girl, Not Yet a Woman” to express his feelings for the stock market.”With apologies […]

Solazyme is Trading Below Cash; Should You Buy?

When it comes to traditional biotech investing — that is, biotech stocks in healthcare — it’s not uncommon for a company to fall dramatically after a negative outcome from a binary event, such as a failed clinical trial. In some instances, development-stage companies with no products on the market and few revenue streams can see their market value fall below […]

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015

The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called “patent cliff.” Driving this point home, the closely watched iShares Nasdaq Biotechnology Index has appreciated a princely 162% since 2012:As earnings across the industry are […]